Resources from the same session
How to select targeted agents for molecular aberrations
Presenter: Rodrigo Dienstmann
Session: Molecular tumour board and drug access
Resources:
Slides
Webcast
Integration of new technology in the identification of molecular targets
Presenter: Ignacio Wistuba
Session: Molecular tumour board and drug access
Industry reaction to new scientific insights
Presenter: Susan Galbraith
Session: Molecular tumour board and drug access
Resources:
Slides
Webcast